Nanoliposomal System for Breast Cancer Therapy

Abstract

In the midst of a plethora of nanomaterial-based drug delivery platforms, liposomes have been predominantly successful with several products conceded into clinical applications. Liposomes are well-established and effective drug delivery systems, extensively used in cancer therapy including breast cancer. In this chapter nanoliposomes designed with the breast cancer targeting feature and drug release triggering functions are emphasized. The chapter also highlights the recent advances in the nanoliposomes-based therapeutic system for breast cancer, including gene and theranostic delivery perspectives. The challenges associated with the development of liposome-based products for future clinical settings are also discussed.